2. Masoodi, M, Kuda, O, Rossmeisl, M, et al. (2015) Lipid signaling in adipose tissue: connecting inflammation & metabolism. Biochim Biophys Acta 1851, 503–518.
3. Van Gaal, LF, Mertens, IL & De Block, CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880.
4. Mushref, MA & Srinivasan, S (2013) Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med 1, 14.
5. Sellbom, KS & Gunstad, J (2012) Cognitive function and decline in obesity. J Alzheimers Dis 30, Suppl. 2, S89–S95.
6. Costa, JV & Duarte, JS (2006) Adipose tissue and adipokines. Acta Med Port 19, 251–256.
7. Coelho, M, Oliveira, T & Fernandes, R (2013) Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 9, 191–200.
8. Vieira-Potter, VJ (2014) Inflammation and macrophage modulation in adipose tissues. Cell Microbiol 16, 1484–1492.
9. Johnson, AR, Milner, JJ & Makowski, L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249, 218–238.
10. Duracková, Z (2010) Some current insights into oxidative stress. Physiol Res 59, 459–469.
11. Bjørklund, G & Chirumbolo, S (2017) Role of oxidative stress and antioxidants in daily nutrition and human health. Nutrition 33, 311–321.
12. Genestra, M (2007) Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19, 1807–1819.
13. Halliwell, B & Gutteridge, JMC (2007) Free Radicals in Biology and Medicine, 4th ed. Oxford: Clarendon Press.
14. Arulselvan, P, Fard, MT, Tan, WS, et al. (2016) Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev 2016, 5276130.
15. Furukawa, S, Fujita, T, Shimabukuro, M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752–1761.
16. Liu, R, Pulliam, DA, Liu, Y, et al. (2015) Dynamic differences in oxidative stress and the regulation of metabolism with age in visceral versus subcutaneous adipose. Redox Biol 6, 401–408.
17. Gesta, S, Tseng, Y-H & Kahn, CR (2007) Developmental origin of fat: tracking obesity to its source. Cell 131, 242–256.
18. Pischon, T, Boeing, H, Hoffmann, K, et al. (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359, 2105–2120.
19. Després, JP (2012) Body fat distribution and risk of cardiovascular disease: an update. Circulation 126, 1301–1313.
20. Qiang, G, Kong, HW, Fang, D, et al. (2016) The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation. Nat Commun 7, 11378.
21. Manna, P & Jain, SK (2015) Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord 13, 423–444.
22. Kawser Hossain, M, Abdal Dayem, A, Han, J, et al. (2016) Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids. Int J Mol Sci 17, 569.
23. Havsteen, BH (2002) The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96, 67–202.
24. Zhang, YJ, Gan, RY, Li, S, et al. (2015) Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 20, 21138–21156.
25. Behloul, N & Wu, G (2013) Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol 698, 31–38.
26. Dong, J, Zhang, X, Zhang, L, et al. (2014) Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1. J Lipid Res 55, 363–374.
27. Zang, Y, Zhang, L, Igarashi, K, et al. (2015) The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice. Food Funct 6, 834–841.
28. Su, HM, Feng, LN, Zheng, XD, et al. (2016) Myricetin protects against diet-induced obesity and ameliorates oxidative stress in C57BL/6 mice. J Zhejiang Univ Sci B 17, 437–446.
29. Feng, X, Yu, W, Li, X, et al. (2017) Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Biochem Pharmacol 136, 136–149.
30. Liu, C, Ma, J, Sun, J, et al. (2017) Flavonoid-rich extract of Paulownia fortunei flowers attenuates diet-induced hyperlipidemia, hepatic steatosis and insulin resistance in obesity mice by AMPK pathway. Nutrients 9, E959.
31. De Groote, D, Van Belleghem, K, Devière, J, et al. (2012) Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects. Ann Nutr Metab 61, 15–24.
32. Azzini, E, Venneria, E, Ciarapica, D, et al. (2017) Effect of red orange juice consumption on body composition and nutritional status in overweight/obese female: a pilot study. Oxid Med Cell Longev 2017, 1672567.
33. Hardy, OT, Czech, MP & Corvera, S (2012) What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 19, 81–87.
34. Nowotny, K, Jung, T, Höhn, A, et al. (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5, 194–222.
35. Scazzocchio, B, Vari, R, Filesi, C, et al. (2011) Cyanidin-3-O-β-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARγ activity in human omental adipocytes. Diabetes 60, 2234–2244.
36. Sasaki, R, Nishimura, N, Hoshino, H, et al. (2007) Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol 74, 1619–1627.
37. Ren, B, Qin, W, Wu, F, et al. (2016) Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur J Pharmacol 773, 13–23.
38. Ahmed, OM, Hassan, MA, Abdel-Twab, SM, et al. (2017) Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats. Biomed Pharmacother 94, 197–205.
39. Alam, MM, Meerza, D & Naseem, I (2014) Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci 109, 8–14.
40. Guo, H, Xia, M, Zou, T, et al. (2012) Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. J Nutr Biochem 23, 349–360.
41. Grosso, G, Stepaniak, U, Micek, A, et al. (2016) Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur J Nutr 56, 1409–1420.
42. Grosso, G, Stepaniak, U, Micek, A, et al. (2017) Dietary polyphenol intake and risk of type 2 diabetes in the Polish arm of the Health, Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) study. Br J Nutr 118, 60–68.
43. Liu, YJ, Zhan, J, Liu, XL, et al. (2014) Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr 33, 59–63.
44. Zheng, XX, Xu, YL, Li, SH, et al. (2013) Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr 97, 750–762.
45. Reho, JJ & Rahmouni, K (2017) Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clin Sci (Lond) 131, 1689–1700.
46. Xia, M, Ling, W, Zhu, H, et al. (2007) Anthocyanin prevents CD40-activated proinflammatory signaling in endothelial cells by regulating cholesterol distribution. Arterioscler Thromb Vasc Biol 27, 519–524.
47. Tribolo, S, Lodi, F, Connor, C, et al. (2008) Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197, 50–56.
48. Yamagata, K, Miyashita, A, Matsufuji, H, et al. (2010) Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor α-induced adhesion molecule expression in human endothelial cells. J Nutr Biochem 21, 116–124.
49. Gandhi, C, Upaganalawar, A & Balaraman, R (2009) Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. Free Radic Res 43, 817–827.
50. Horáková, L (2011) Flavonoids in prevention of diseases with respect to modulation of Ca-pump function. Interdiscip Toxicol 4, 114–124.
51. Alam, MA, Kauter, K & Brown, L (2013) Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients 5, 637–650.
52. Mykkänen, OT, Huotari, A, Herzig, KH, et al. (2014) Wild blueberries (Vaccinium myrtillus) alleviate inflammation and hypertension associated with developing obesity in mice fed with a high-fat diet. PLOS ONE 9, e114790.
53. Babu, PV, Si, H, Fu, Z, et al. (2012) Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. J Nutr 142, 724–730.
54. Clerici, C, Setchell, KD, Battezzati, PM, et al. (2007) Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 137, 2270–2278.
55. Chong, MF, Macdonald, R & Lovegrove, JA (2010) Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr 104, Suppl. 3, S28–S39.
56. Sebastian, RS, Wilkinson Enns, C, Goldman, JD, et al. (2017) Dietary flavonoid intake is inversely associated with cardiovascular disease risk as assessed by body mass index and waist circumference among adults in the United States. Nutrients 9, E827.
57. Ho, W & Spiegel, BM (2008) The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither? Gastroenterol Hepatol 4, 572–578.
58. Buchoucha, M, Fysekidis, M, Julia, C, et al. (2015) Functional gastrointestinal disorders in obese patients. The importance of the enrollment source. Obes Surg 25, 2143–2152.
59. Bhattarai, Y, Fried, D, Gulbransen, B, et al. (2016) High-fat diet-induced obesity alters nitric oxide-mediated neuromuscular transmission and smooth muscle excitability in the mouse distal colon. Am J Physiol Gastrointest Liver Physiol 311, G210–G220.
60. Antonioli, L, Pellegrini, C, Fornai, M, et al. (2017) Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors. Purinergic Signal 13, 497–510.
61. Anitha, M, Reichardt, F, Tabatabavakili, S, et al. (2016) Intestinal dysbiosis contributes to the delayed gastrointestinal transit in high-fat diet fed mice. Cell Mol Gastroenterol Hepatol 2, 328–339.
62. Raybould, HE (2012) Gut microbiota, epithelial function and derangements in obesity. J Physiol 590, 441–446.
63. Kim, KA, Gu, W, Lee, IA, et al. (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLOS ONE 7, e47713.
64. Stenman, LK, Holma, R & Korpela, R (2012) High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 18, 923–929.
65. Savini, I, Catani, MV, Evangelista, D, et al. (2013) Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 14, 10497–10538.
66. Gil-Cardoso, K, Ginés, I, Pinent, M, et al. (2016) Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity. Nutr Res Rev 29, 234–248.
67. Yasui, K, Tanabe, H, Miyoshi, N, et al. (2011) Effects of (–)-epigallocatechin-3-O-gallate on expression of gluconeogenesis-related genes in the mouse duodenum. Biomed Res 32, 313–320.
68. Anhê, FF, Roy, D, Pilon, G, et al. (2015) A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64, 872–883.
69. Roopchand, DE, Carmody, RN, Kuhn, P, et al. (2015) Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64, 2847–2858.
70. Gentile, D, Fornai, M, Colucci, R, et al. (2018) The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity. PLOS ONE 13, e0195502.
71. Wang, C, Chan, JS, Ren, L, et al. (2016) Obesity reduces cognitive and motor functions across the lifespan. Neural Plast 2016, 2473081.
72. Benito-León, J, Mitchell, AJ, Hernández-Gallego, J, et al. (2013) Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol 20, 899–906, e76–e77.
73. Wang, D, Yan, J, Chen, J, et al. (2015) Naringin improves neuronal insulin signaling, brain mitochondrial function, and cognitive function in high-fat diet-induced obese mice. Cell Mol Neurobiol 35, 1061–1071.
74. Orhan, IE, Daglia, M, Nabavi, SF, et al. (2015) Flavonoids and dementia: an update. Curr Med Chem 22, 1004–1015.
75. Unno, K, Yamamoto, H, Maeda, K, et al. (2009) Protection of brain and pancreas from high-fat diet: effects of catechin and caffeine. Physiol Behav 96, 262–269.
76. Liu, Y, Fu, X, Lan, N, et al. (2014) Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav Brain Res 267, 178–188.
77. Johnson, RW (2015) Feeding the beast: can microglia in the senescent brain be regulated by diet? Brain Behav Immun 43, 1–8.
78. Fernando, WMADB, Somaratne, G, Goozee, KG, et al. (2017) Diabetes and Alzheimer’s disease: can tea phytochemicals play a role in prevention? J Alzheimers Dis 59, 481–501.